{"bekendtgoerelseNoegle":{"noticeId":{"value":"7bb3386e-bc97-41a2-a449-e938965a8d4c"},"noticeVersion":{"value":"01"},"noticePublicationNumber":{"value":"00850409-2025"}},"htmlDA":"\n\n \n
1 Køber
1.1 Køber
Officielt navn: NHS National Services Scotland (NSS)
\n
Køberens retlige status: Offentligretligt organ
\n
Den ordregivende myndigheds aktivitet: Sundhed
\n
\n
1.1 Køber
Officielt navn: Servizo Gallego de Salud – Area Sanitaria de Lugo, A Marina y Monforte de Lemos
\n
Køberens retlige status: Offentligretligt organ
\n
Den ordregivende myndigheds aktivitet: Sundhed
\n
\n
1.1 Køber
Officielt navn: Region Hovedstaden (REGIONH)
\n
Køberens retlige status: Offentligretligt organ
\n
Den ordregivende myndigheds aktivitet: Sundhed
\n
\n
1.1 Køber
Officielt navn: Fundacja Klaster Lifescience Krakow (KLSK)
\n
Køberens retlige status: Offentligretligt organ
\n
Den ordregivende myndigheds aktivitet: Sundhed
\n
\n
1.1 Køber
Officielt navn: Mitera Idiotiki Geniki, Maieytiki, Gynaikologiki Kai Paidiatriki Kliniki Anonymi Etaireia\n (MITERA)
\n
Køberens retlige status: Offentligretligt organ
\n
Den ordregivende myndigheds aktivitet: Sundhed
\n
\n
\n
2 Procedure
2.1 Procedure
Titel: PreCommercial Procurement (PCP) to buy R&D (research and development) services on\n innovative and sustainable solutions to transition healthcare supply chains from linear\n to circular models – REHEAL.
\n
Beskrivelse: This PIN provides early information about the expected starting date and purchase\n volume and about the open market consultation that is organised in preparation of\n this precommercial procurement (PCP). The procurement aims to trigger new solutions\n to be developed and tested to address the following challenge: REHEAL aims to stimulate\n the development of new solutions that will support the transition of healthcare supply\n chains from linear to circular models to enhance sustainability and resilience. Key\n areas include developing supply chain management platforms that prioritise product\n longevity, material tracking, and regulatory compliance, employing advanced data analytics\n and AI to optimise reverse logistics and explore recovery opportunities. Solutions\n should enable scenario analysis and modelling, allowing healthcare providers to identify\n and implement the most impactful strategies tailored to regional needs.
\n
2.1.1 Formål
Kontraktens hovedformål: Tjenesteydelser
\n
Primær klassifikation (cpv): 73100000 Forskning og eksperimentel udvikling
\n
Supplerende klassifikation (cpv): 73110000 Forskning
\n
Supplerende klassifikation (cpv): 72212445 Udvikling af programmel til håndtering af kundeoplysninger og -relationer (CRM)
\n
Supplerende klassifikation (cpv): 72222300 Tjenesteydelser i forbindelse med informationsteknologi
\n
Supplerende klassifikation (cpv): 90713000 Rådgivning i forbindelse med miljøspørgsmål
\n
Supplerende klassifikation (cpv): 90714100 Miljøoplysningssystemer
\n
Supplerende klassifikation (cpv): 90711300 Analyse af miljøindikatorer for andet end bygge- og anlægsarbejder
\n
Supplerende klassifikation (cpv): 80500000 Uddannelsestilbud
\n
Supplerende klassifikation (cpv): 79342200 Servicevirksomhed i forbindelse med salgsfremme
\n
Supplerende klassifikation (cpv): 90711000 Miljøvurdering for andet end bygge- og anlægsarbejder
\n
Supplerende klassifikation (cpv): 72212783 Udvikling af programmel til indholdsforvaltning
\n
Supplerende klassifikation (cpv): 85100000 Tjenesteydelser inden for sundhedsvæsenet
\n
\n
2.1.2 Udførelsessted
By: Edinburgh
\n
Postnummer: EH12 9EB
\n
Land: Det Forenede Kongerige
\n
Yderligere oplysninger: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark\n (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
\n
\n
2.1.2 Udførelsessted
By: Lugo
\n
Landsdel (NUTS): Lugo (ES112)
\n
Land: Spanien
\n
Yderligere oplysninger: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark\n (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
\n
\n
2.1.2 Udførelsessted
By: Copenhagen
\n
Landsdel (NUTS): Københavns omegn (DK012)
\n
Land: Danmark
\n
Yderligere oplysninger: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark\n (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
\n
\n
2.1.2 Udførelsessted
By: Kraków
\n
Landsdel (NUTS): Miasto Kraków (PL213)
\n
Land: Polen
\n
Yderligere oplysninger: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark\n (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
\n
\n
2.1.2 Udførelsessted
By: Attiki
\n
Landsdel (NUTS): Δυτική Αττική (EL306)
\n
Land: Grækenland
\n
Yderligere oplysninger: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark\n (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
\n
\n
2.1.3 Værdi
Anslået værdi eksklusiv moms: 3.000.000 Euro
\n
\n
2.1.4 Generelle oplysninger
Yderligere oplysninger: The research and development (R&D) services will be carried out primarily within the\n European Union and/or in countries associated with the Horizon Europe Programme. At\n least 50% of the total value of the R&D activities shall take place within the EU\n or associated countries. Contractors must ensure that none of the contracted services\n are performed in countries nor by entities that are subject to EU restrictive measures\n under Article 29 of the Treaty on the European Union (TEU) and Article 215 of the\n Treaty on the Functioning of the EU (TFEU)23 (sanctions). They must also ensure that\n none of the goods procured or used for the procurement were developed, produced or\n supplied in countries or by entities that are subject to such restrictive measures.\n This procurement is exempted from the WTO Government Procurement Agreement (GPA),\n the EU public procurement directives and the national laws that implement them. This\n is because it concerns the procurement of R&D services where the benefits do not accrue\n exclusively to the contracting authority for its use in the conduct of its own affairs.\n Publication of this contract notice in the EU Official Journal is not to be understood\n as a waiver of this exemption. Publication is made on a voluntary basis and the procurement\n will not follow the procedures under the EU public procurement directives, but rather\n the procedure described in the tender documentation. This PIN is published to announce\n an open market consultation on a future procurement procedure. The PIN is not a commitment\n to procure. This procurement is funded by the European Union's Horizon Europe Research\n and Innovation Programme under Grant Agreement No. 101226919 – ReHEAL https://www.rehealhorizon.eu\n . *The EU has awarded a grant for this procurement but is not participating as a contracting\n authority in the procurement.* For additional information, please contact: REHEAL\n Project Coordination Team, Email:pcp@rehealhorizon.eu More information is on the REHEAL\n website https://www.rehealhorizon.eu.
\n
Retsgrundlag:
\n
Anden
\n
\n
\n
\n
3 Del
3.1 Teknisk ID for delen: PAR-0001
Titel: PreCommercial Procurement (PCP) to buy R&D (research and development) services on\n innovative and sustainable solutions to transition healthcare supply chains from linear\n to circular models – REHEAL.
\n
Beskrivelse: This PCP procurement is a joint procurement by different procurers across Europe that\n are all facing the same common challenge and are thus looking for similar solutions\n (socalled ‘Buyers Group’).The procurement will take the form of a precommercial procurement\n (PCP) under which R&D service contracts will be awarded to a number of R&D providers\n in parallel in a phased approach. This will make it possible to compare competing\n alternative solutions. Each selected R&D provider will be awarded a framework agreement\n that covers the following R&D phases and a specific contract per phase.Procurement\n will take the form of a precommercial procurement (PCP), that will allow procurers\n to buy R&D from several competing suppliers in parallel; to compare alternative solution\n approaches and to identify the best valueformoney solutions that the market can deliver\n to address those needs. The PCP will be structured as a fasttrack PCP, specifically\n designed to accelerate innovation cycles and reduce timetoimpact whilst remaining\n fully compliant with Horizon Europe PCP principles. In contrast to traditional PCPs\n that strictly separate prototyping and piloting into distinct phases, REHEAL adopts\n a fasttrack approach in which prototyping and piloting are combined into a single\n integrated R&D phase. This approach is justified by the digital, softwareintensive\n nature of the expected solutions, which enables rapid iteration, continuous testing\n and early validation in real operational environments. The PCP will be organised into\n three consecutive phases: Phase 1 – Solution design and feasibility: Selected contractors\n will elaborate detailed solution designs, technical architectures, and feasibility\n studies addressing the REHEAL challenge, including risk assessment and validation\n plans. Phase 2 – Prototyping and piloting (combined phase): Contractors will develop\n functional prototypes and pilot them directly in operational healthcare environments\n across the Buyers Group sites. Prototyping and piloting are grouped together to enable\n rapid learning loops, realworld testing, and early assessment of usability, scalability,\n sustainability impact, and integration into existing healthcare supply chains. Phase\n 3 – followup procurement: subject to the successful completion of Phase 2 and availability\n of funding, the REHEAL Buyers Group may launch a separate followup procurement to\n deploy and upscale the most promising solution(s). This Phase 3 is not part of the\n PCP itself, but is foreseen as a potential next step to ensure market uptake and impact,\n in line with Horizon Europe PCP guidance. After each PCP phase, interim evaluations\n will be carried out, and the contractors offering the best value for money will be\n invited to progress to the next phase. Each selected operator will receive a framework\n contract, with specific contracts awarded per phase. The selected operators will retain\n ownership of the intellectual property rights (IPRs) they generate during the PCP\n and will be able to use them to exploit the full market potential of the solutions\n developed. All interested operators are invited to take part in the upcoming open\n market consultation (OMC) (regardless of their geographic location, size or governance\n structure of their organisation). The OMC will be organised as a series of meetings.\n These meetings will provide you with an overview on the procurement objectives, the\n PCP process and the main clauses of the contract. You will also have the opportunity\n to ask questions. A first EUlevel online webinar will be held on 11 February 2026,\n introducing the project, challenge, requirements, Buyers Group, overall PCP process\n and timeline, to tools available to support applicants. This will be followed by a\n series of five live meetings hosted in each of the procurer locations mentioned in\n under Section I.1) During those meetings, the procurers will offer presentations in\n their own local languages, namely English, Spanish, Danish, Polish and Greek. These\n meetings will take place between 16 – 27 February 2026. The meetings will be followed\n by an EUlevel live event on 4 March and a final EU webinar, on 31 March 2026, in English.\n Registration for OMC meetings will be available on the REHEAL website https://www.rehealhorizon.eu\n – from 19 January 2026. The contract notice is expected to be published in July 2026\n and the procurement is expected to start in late 2026 and end in late 2028. Testing\n is expected to take place in Scotland (UK), Galicia (Spain), Region Hovedstaden (Denmark),\n Krakow (Poland), and Athens (Greece). This testing may also serve as a first customer\n test reference for the contractors. The selected suppliers will retain ownership of\n the intellectual property rights (IPRs) they generate during the PCP and will be able\n to use them to exploit the full market potential of the solutions developed, i.e.\n beyond the procurement.
\n
3.1.1 Formål
Kontraktens hovedformål: Tjenesteydelser
\n
Primær klassifikation (cpv): 73100000 Forskning og eksperimentel udvikling
\n
\n
3.1.2 Udførelsessted
By: Edinburgh
\n
Land: Det Forenede Kongerige
\n
Yderligere oplysninger: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark\n (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
\n
\n
3.1.2 Udførelsessted
By: Lugo
\n
Landsdel (NUTS): Lugo (ES112)
\n
Land: Spanien
\n
Yderligere oplysninger: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark\n (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
\n
\n
3.1.2 Udførelsessted
By: Copenhagen
\n
Landsdel (NUTS): Københavns omegn (DK012)
\n
Land: Danmark
\n
Yderligere oplysninger: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark\n (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
\n
\n
3.1.2 Udførelsessted
By: Kraków
\n
Landsdel (NUTS): Miasto Kraków (PL213)
\n
Land: Polen
\n
Yderligere oplysninger: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark\n (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
\n
\n
3.1.2 Udførelsessted
By: Attiki
\n
Landsdel (NUTS): Δυτική Αττική (EL306)
\n
Land: Grækenland
\n
Yderligere oplysninger: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark\n (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
\n
\n
3.1.3 Varighed
Anden varighed: Ukendt
\n
\n
3.1.4 Værdi
Anslået værdi eksklusiv moms: 3.000.000 Euro
\n
\n
3.1.5 Generelle oplysninger
Udbuddet er omfattet af aftalen om offentlige udbud (GPA): nej
\n
Dette udbud er også egnet for små og mellemstore virksomheder (SMV'er): ja
\n
\n
3.1.9 Yderligere oplysninger, mægling og gennemgang
Organisation med ansvar for mægling: NHS National Services Scotland (NSS)
\n
Organisation med ansvar for klager: NHS National Services Scotland (NSS)
\n
Organisation, der leverer yderligere oplysninger om klageprocedurerne: NHS National Services Scotland (NSS)
\n
\n
\n
\n
8 Organisationer
8.1 ORG-0001
Officielt navn: NHS National Services Scotland (NSS)
\n
Registreringsnummer: GB 654 851 612
\n
Postadresse: 1 South Gyle Crescent  
\n
By: Edinburgh
\n
Postnummer: EH12 9EB
\n
Land: Det Forenede Kongerige
\n
Enhed: REHEAL Coordination Team
\n
E-mail: pcp@rehealhorizon.eu
\n
Telefon: +44 1312756000
\n
Internetadresse: https://www.rehealhorizon.eu
\n
Køberprofil: https://www.rehealhorizon.eu
\n
Denne organisations roller:
Køber
\n
Organisation med ansvar for klager
\n
Organisation, der leverer yderligere oplysninger om klageprocedurerne
\n
Organisation med ansvar for mægling
\n
\n
\n
8.1 ORG-0002
Officielt navn: Servizo Gallego de Salud – Area Sanitaria de Lugo, A Marina y Monforte de Lemos
\n
Registreringsnummer: Q2729003A
\n
Postadresse: Doctor Ulises Romero No. 1 – 2a planta  
\n
By: Lugo
\n
Postnummer: 27003
\n
Landsdel (NUTS): Lugo (ES112)
\n
Land: Spanien
\n
Enhed: REHEAL Coordination Team
\n
E-mail: pcp@rehealhorizon.eu
\n
Telefon: +34 981580633
\n
Internetadresse: https://www.rehealhorizon.eu
\n
Køberprofil: https://www.rehealhorizon.eu
\n
Denne organisations roller:
Køber
\n
\n
\n
8.1 ORG-0003
Officielt navn: Region Hovedstaden (REGIONH)
\n
Registreringsnummer: 30113721
\n
Postadresse: Regionsgården – Kongens Vænge 2  
\n
By: Hillerød
\n
Postnummer: 3400
\n
Landsdel (NUTS): Københavns omegn (DK012)
\n
Land: Danmark
\n
Enhed: REHEAL Coordination Team
\n
E-mail: pcp@rehealhorizon.eu
\n
Telefon: +45 21537888
\n
Internetadresse: https://www.rehealhorizon.eu
\n
Køberprofil: https://www.rehealhorizon.eu
\n
Denne organisations roller:
Køber
\n
\n
\n
8.1 ORG-0004
Officielt navn: Fundacja Klaster Lifescience Krakow (KLSK)
\n
Registreringsnummer: 0000458418
\n
Postadresse: Bobrzyńskiego 14  
\n
By: Kraków
\n
Postnummer: 30-348
\n
Landsdel (NUTS): Miasto Kraków (PL213)
\n
Land: Polen
\n
Enhed: REHEAL Coordination Team
\n
E-mail: pcp@rehealhorizon.eu
\n
Telefon: +48 789 490 146
\n
Internetadresse: https://www.rehealhorizon.eu
\n
Køberprofil: https://www.rehealhorizon.eu
\n
Denne organisations roller:
Køber
\n
\n
\n
8.1 ORG-0005
Officielt navn: Mitera Idiotiki Geniki, Maieytiki, Gynaikologiki Kai Paidiatriki Kliniki Anonymi Etaireia\n (MITERA)
\n
Registreringsnummer: 000288501000 (GEMI)
\n
Postadresse: 6, Erythrou Stavrou  
\n
By: Marousi, Athens
\n
Postnummer: 15123
\n
Landsdel (NUTS): Δυτική Αττική (EL306)
\n
Land: Grækenland
\n
Enhed: REHEAL Coordination Team
\n
E-mail: pcp@rehealhorizon.eu
\n
Telefon: +30 2117508697
\n
Internetadresse: https://www.rehealhorizon.eu
\n
Køberprofil: https://www.rehealhorizon.eu
\n
Denne organisations roller:
Køber
\n
\n
\n
8.1 ORG-0000
Officielt navn: Publications Office of the European Union
\n
Registreringsnummer: PUBL
\n
By: Luxembourg
\n
Postnummer: 2417
\n
Landsdel (NUTS): Luxembourg (LU000)
\n
Land: Luxembourg
\n
E-mail: ted@publications.europa.eu
\n
Telefon: +352 29291
\n
Internetadresse: https://op.europa.eu
\n
Denne organisations roller:
TED eSender
\n
\n
\n
\n
Oplysninger om bekendtgørelsen
Bekendtgørelsens ID: 7bb3386e-bc97-41a2-a449-e938965a8d4c - 01
\n
Formulartype: Planlægning
\n
Bekendtgørelsestype: Forhåndsmeddelelse eller vejledende periodisk bekendtgørelse, der kun er anvendt til informationsformål
\n
Afsendelsesdato for bekendtgørelsen: 19-12-2025 11:00 +00:00
\n
Bekendtgørelsens officielle sprog: engelsk 
\n
Bekendtgørelsesnummer: 00850409-2025
\n
EUT-S-nummer: 246/2025
\n
Offentliggørelsesdato: 22-12-2025
\n
Den påtænkte dato for offentliggørelse af en udbudsbekendtgørelse inden for denne procedure: 16-06-2026
\n
\n \n","htmlEN":"\n\n \n
1 Buyer
1.1 Buyer
Official name: NHS National Services Scotland (NSS)
\n
Legal type of the buyer: Body governed by public law
\n
Activity of the contracting authority: Health
\n
\n
1.1 Buyer
Official name: Servizo Gallego de Salud – Area Sanitaria de Lugo, A Marina y Monforte de Lemos
\n
Legal type of the buyer: Body governed by public law
\n
Activity of the contracting authority: Health
\n
\n
1.1 Buyer
Official name: Region Hovedstaden (REGIONH)
\n
Legal type of the buyer: Body governed by public law
\n
Activity of the contracting authority: Health
\n
\n
1.1 Buyer
Official name: Fundacja Klaster Lifescience Krakow (KLSK)
\n
Legal type of the buyer: Body governed by public law
\n
Activity of the contracting authority: Health
\n
\n
1.1 Buyer
Official name: Mitera Idiotiki Geniki, Maieytiki, Gynaikologiki Kai Paidiatriki Kliniki Anonymi Etaireia\n (MITERA)
\n
Legal type of the buyer: Body governed by public law
\n
Activity of the contracting authority: Health
\n
\n
\n
2 Procedure
2.1 Procedure
Title: PreCommercial Procurement (PCP) to buy R&D (research and development) services on\n innovative and sustainable solutions to transition healthcare supply chains from linear\n to circular models – REHEAL.
\n
Description: This PIN provides early information about the expected starting date and purchase\n volume and about the open market consultation that is organised in preparation of\n this precommercial procurement (PCP). The procurement aims to trigger new solutions\n to be developed and tested to address the following challenge: REHEAL aims to stimulate\n the development of new solutions that will support the transition of healthcare supply\n chains from linear to circular models to enhance sustainability and resilience. Key\n areas include developing supply chain management platforms that prioritise product\n longevity, material tracking, and regulatory compliance, employing advanced data analytics\n and AI to optimise reverse logistics and explore recovery opportunities. Solutions\n should enable scenario analysis and modelling, allowing healthcare providers to identify\n and implement the most impactful strategies tailored to regional needs.
\n
2.1.1 Purpose
Main nature of the contract: Services
\n
Main classification (cpv): 73100000 Research and experimental development services
\n
Additional classification (cpv): 73110000 Research services
\n
Additional classification (cpv): 72212445 Customer Relation Management software development services
\n
Additional classification (cpv): 72222300 Information technology services
\n
Additional classification (cpv): 90713000 Environmental issues consultancy services
\n
Additional classification (cpv): 90714100 Environmental information systems
\n
Additional classification (cpv): 90711300 Environmental indicators analysis other than for construction
\n
Additional classification (cpv): 80500000 Training services
\n
Additional classification (cpv): 79342200 Promotional services
\n
Additional classification (cpv): 90711000 Environmental impact assessment other than for construction
\n
Additional classification (cpv): 72212783 Content management software development services
\n
Additional classification (cpv): 85100000 Health services
\n
\n
2.1.2 Place of performance
Town: Edinburgh
\n
Postcode: EH12 9EB
\n
Country: United Kingdom
\n
Additional information: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark\n (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
\n
\n
2.1.2 Place of performance
Town: Lugo
\n
Country subdivision (NUTS): Lugo (ES112)
\n
Country: Spain
\n
Additional information: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark\n (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
\n
\n
2.1.2 Place of performance
Town: Copenhagen
\n
Country subdivision (NUTS): Københavns omegn (DK012)
\n
Country: Denmark
\n
Additional information: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark\n (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
\n
\n
2.1.2 Place of performance
Town: Kraków
\n
Country subdivision (NUTS): Miasto Kraków (PL213)
\n
Country: Poland
\n
Additional information: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark\n (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
\n
\n
2.1.2 Place of performance
Town: Attiki
\n
Country subdivision (NUTS): Δυτική Αττική (EL306)
\n
Country: Greece
\n
Additional information: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark\n (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
\n
\n
2.1.3 Value
Estimated value excluding VAT: 3.000.000 Euro
\n
\n
2.1.4 General information
Additional information: The research and development (R&D) services will be carried out primarily within the\n European Union and/or in countries associated with the Horizon Europe Programme. At\n least 50% of the total value of the R&D activities shall take place within the EU\n or associated countries. Contractors must ensure that none of the contracted services\n are performed in countries nor by entities that are subject to EU restrictive measures\n under Article 29 of the Treaty on the European Union (TEU) and Article 215 of the\n Treaty on the Functioning of the EU (TFEU)23 (sanctions). They must also ensure that\n none of the goods procured or used for the procurement were developed, produced or\n supplied in countries or by entities that are subject to such restrictive measures.\n This procurement is exempted from the WTO Government Procurement Agreement (GPA),\n the EU public procurement directives and the national laws that implement them. This\n is because it concerns the procurement of R&D services where the benefits do not accrue\n exclusively to the contracting authority for its use in the conduct of its own affairs.\n Publication of this contract notice in the EU Official Journal is not to be understood\n as a waiver of this exemption. Publication is made on a voluntary basis and the procurement\n will not follow the procedures under the EU public procurement directives, but rather\n the procedure described in the tender documentation. This PIN is published to announce\n an open market consultation on a future procurement procedure. The PIN is not a commitment\n to procure. This procurement is funded by the European Union's Horizon Europe Research\n and Innovation Programme under Grant Agreement No. 101226919 – ReHEAL https://www.rehealhorizon.eu\n . *The EU has awarded a grant for this procurement but is not participating as a contracting\n authority in the procurement.* For additional information, please contact: REHEAL\n Project Coordination Team, Email:pcp@rehealhorizon.eu More information is on the REHEAL\n website https://www.rehealhorizon.eu.
\n
Legal basis:
\n
Other
\n
\n
\n
\n
3 Part
3.1 Part technical ID: PAR-0001
Title: PreCommercial Procurement (PCP) to buy R&D (research and development) services on\n innovative and sustainable solutions to transition healthcare supply chains from linear\n to circular models – REHEAL.
\n
Description: This PCP procurement is a joint procurement by different procurers across Europe that\n are all facing the same common challenge and are thus looking for similar solutions\n (socalled ‘Buyers Group’).The procurement will take the form of a precommercial procurement\n (PCP) under which R&D service contracts will be awarded to a number of R&D providers\n in parallel in a phased approach. This will make it possible to compare competing\n alternative solutions. Each selected R&D provider will be awarded a framework agreement\n that covers the following R&D phases and a specific contract per phase.Procurement\n will take the form of a precommercial procurement (PCP), that will allow procurers\n to buy R&D from several competing suppliers in parallel; to compare alternative solution\n approaches and to identify the best valueformoney solutions that the market can deliver\n to address those needs. The PCP will be structured as a fasttrack PCP, specifically\n designed to accelerate innovation cycles and reduce timetoimpact whilst remaining\n fully compliant with Horizon Europe PCP principles. In contrast to traditional PCPs\n that strictly separate prototyping and piloting into distinct phases, REHEAL adopts\n a fasttrack approach in which prototyping and piloting are combined into a single\n integrated R&D phase. This approach is justified by the digital, softwareintensive\n nature of the expected solutions, which enables rapid iteration, continuous testing\n and early validation in real operational environments. The PCP will be organised into\n three consecutive phases: Phase 1 – Solution design and feasibility: Selected contractors\n will elaborate detailed solution designs, technical architectures, and feasibility\n studies addressing the REHEAL challenge, including risk assessment and validation\n plans. Phase 2 – Prototyping and piloting (combined phase): Contractors will develop\n functional prototypes and pilot them directly in operational healthcare environments\n across the Buyers Group sites. Prototyping and piloting are grouped together to enable\n rapid learning loops, realworld testing, and early assessment of usability, scalability,\n sustainability impact, and integration into existing healthcare supply chains. Phase\n 3 – followup procurement: subject to the successful completion of Phase 2 and availability\n of funding, the REHEAL Buyers Group may launch a separate followup procurement to\n deploy and upscale the most promising solution(s). This Phase 3 is not part of the\n PCP itself, but is foreseen as a potential next step to ensure market uptake and impact,\n in line with Horizon Europe PCP guidance. After each PCP phase, interim evaluations\n will be carried out, and the contractors offering the best value for money will be\n invited to progress to the next phase. Each selected operator will receive a framework\n contract, with specific contracts awarded per phase. The selected operators will retain\n ownership of the intellectual property rights (IPRs) they generate during the PCP\n and will be able to use them to exploit the full market potential of the solutions\n developed. All interested operators are invited to take part in the upcoming open\n market consultation (OMC) (regardless of their geographic location, size or governance\n structure of their organisation). The OMC will be organised as a series of meetings.\n These meetings will provide you with an overview on the procurement objectives, the\n PCP process and the main clauses of the contract. You will also have the opportunity\n to ask questions. A first EUlevel online webinar will be held on 11 February 2026,\n introducing the project, challenge, requirements, Buyers Group, overall PCP process\n and timeline, to tools available to support applicants. This will be followed by a\n series of five live meetings hosted in each of the procurer locations mentioned in\n under Section I.1) During those meetings, the procurers will offer presentations in\n their own local languages, namely English, Spanish, Danish, Polish and Greek. These\n meetings will take place between 16 – 27 February 2026. The meetings will be followed\n by an EUlevel live event on 4 March and a final EU webinar, on 31 March 2026, in English.\n Registration for OMC meetings will be available on the REHEAL website https://www.rehealhorizon.eu\n – from 19 January 2026. The contract notice is expected to be published in July 2026\n and the procurement is expected to start in late 2026 and end in late 2028. Testing\n is expected to take place in Scotland (UK), Galicia (Spain), Region Hovedstaden (Denmark),\n Krakow (Poland), and Athens (Greece). This testing may also serve as a first customer\n test reference for the contractors. The selected suppliers will retain ownership of\n the intellectual property rights (IPRs) they generate during the PCP and will be able\n to use them to exploit the full market potential of the solutions developed, i.e.\n beyond the procurement.
\n
3.1.1 Purpose
Main nature of the contract: Services
\n
Main classification (cpv): 73100000 Research and experimental development services
\n
\n
3.1.2 Place of performance
Town: Edinburgh
\n
Country: United Kingdom
\n
Additional information: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark\n (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
\n
\n
3.1.2 Place of performance
Town: Lugo
\n
Country subdivision (NUTS): Lugo (ES112)
\n
Country: Spain
\n
Additional information: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark\n (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
\n
\n
3.1.2 Place of performance
Town: Copenhagen
\n
Country subdivision (NUTS): Københavns omegn (DK012)
\n
Country: Denmark
\n
Additional information: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark\n (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
\n
\n
3.1.2 Place of performance
Town: Kraków
\n
Country subdivision (NUTS): Miasto Kraków (PL213)
\n
Country: Poland
\n
Additional information: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark\n (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
\n
\n
3.1.2 Place of performance
Town: Attiki
\n
Country subdivision (NUTS): Δυτική Αττική (EL306)
\n
Country: Greece
\n
Additional information: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark\n (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
\n
\n
3.1.3 Duration
Other duration: Unknown
\n
\n
3.1.4 Value
Estimated value excluding VAT: 3.000.000 Euro
\n
\n
3.1.5 General information
The procurement is covered by the Government Procurement Agreement (GPA): no
\n
This procurement is also suitable for small and medium-sized enterprises (SMEs): yes
\n
\n
3.1.9 Further information, mediation and review
Mediation organisation: NHS National Services Scotland (NSS)
\n
Review organisation: NHS National Services Scotland (NSS)
\n
Organisation providing more information on the review procedures: NHS National Services Scotland (NSS)
\n
\n
\n
\n
8 Organisations
8.1 ORG-0001
Official name: NHS National Services Scotland (NSS)
\n
Registration number: GB 654 851 612
\n
Postal address: 1 South Gyle Crescent  
\n
Town: Edinburgh
\n
Postcode: EH12 9EB
\n
Country: United Kingdom
\n
Contact point: REHEAL Coordination Team
\n
Email: pcp@rehealhorizon.eu
\n
Telephone: +44 1312756000
\n
Internet address: https://www.rehealhorizon.eu
\n
Buyer profile: https://www.rehealhorizon.eu
\n
Roles of this organisation:
Buyer
\n
Review organisation
\n
Organisation providing more information on the review procedures
\n
Mediation organisation
\n
\n
\n
8.1 ORG-0002
Official name: Servizo Gallego de Salud – Area Sanitaria de Lugo, A Marina y Monforte de Lemos
\n
Registration number: Q2729003A
\n
Postal address: Doctor Ulises Romero No. 1 – 2a planta  
\n
Town: Lugo
\n
Postcode: 27003
\n
Country subdivision (NUTS): Lugo (ES112)
\n
Country: Spain
\n
Contact point: REHEAL Coordination Team
\n
Email: pcp@rehealhorizon.eu
\n
Telephone: +34 981580633
\n
Internet address: https://www.rehealhorizon.eu
\n
Buyer profile: https://www.rehealhorizon.eu
\n
Roles of this organisation:
Buyer
\n
\n
\n
8.1 ORG-0003
Official name: Region Hovedstaden (REGIONH)
\n
Registration number: 30113721
\n
Postal address: Regionsgården – Kongens Vænge 2  
\n
Town: Hillerød
\n
Postcode: 3400
\n
Country subdivision (NUTS): Københavns omegn (DK012)
\n
Country: Denmark
\n
Contact point: REHEAL Coordination Team
\n
Email: pcp@rehealhorizon.eu
\n
Telephone: +45 21537888
\n
Internet address: https://www.rehealhorizon.eu
\n
Buyer profile: https://www.rehealhorizon.eu
\n
Roles of this organisation:
Buyer
\n
\n
\n
8.1 ORG-0004
Official name: Fundacja Klaster Lifescience Krakow (KLSK)
\n
Registration number: 0000458418
\n
Postal address: Bobrzyńskiego 14  
\n
Town: Kraków
\n
Postcode: 30-348
\n
Country subdivision (NUTS): Miasto Kraków (PL213)
\n
Country: Poland
\n
Contact point: REHEAL Coordination Team
\n
Email: pcp@rehealhorizon.eu
\n
Telephone: +48 789 490 146
\n
Internet address: https://www.rehealhorizon.eu
\n
Buyer profile: https://www.rehealhorizon.eu
\n
Roles of this organisation:
Buyer
\n
\n
\n
8.1 ORG-0005
Official name: Mitera Idiotiki Geniki, Maieytiki, Gynaikologiki Kai Paidiatriki Kliniki Anonymi Etaireia\n (MITERA)
\n
Registration number: 000288501000 (GEMI)
\n
Postal address: 6, Erythrou Stavrou  
\n
Town: Marousi, Athens
\n
Postcode: 15123
\n
Country subdivision (NUTS): Δυτική Αττική (EL306)
\n
Country: Greece
\n
Contact point: REHEAL Coordination Team
\n
Email: pcp@rehealhorizon.eu
\n
Telephone: +30 2117508697
\n
Internet address: https://www.rehealhorizon.eu
\n
Buyer profile: https://www.rehealhorizon.eu
\n
Roles of this organisation:
Buyer
\n
\n
\n
8.1 ORG-0000
Official name: Publications Office of the European Union
\n
Registration number: PUBL
\n
Town: Luxembourg
\n
Postcode: 2417
\n
Country subdivision (NUTS): Luxembourg (LU000)
\n
Country: Luxembourg
\n
Email: ted@publications.europa.eu
\n
Telephone: +352 29291
\n
Internet address: https://op.europa.eu
\n
Roles of this organisation:
TED eSender
\n
\n
\n
\n
Notice information
Notice identifier/version: 7bb3386e-bc97-41a2-a449-e938965a8d4c - 01
\n
Form type: Planning
\n
Notice type: Prior information notice or a periodic indicative notice used only for information
\n
Notice dispatch date: 19-12-2025 11:00 +00:00
\n
Languages in which this notice is officially available: English 
\n
Notice publication number: 00850409-2025
\n
OJ S issue number: 246/2025
\n
Publication date: 22-12-2025
\n
Estimated date of publication of a contract notice within this procedure: 16-06-2026
\n
\n \n","opsummeringDA":{"card":{"titel":"PreCommercial Procurement (PCP) to buy R&D (research and development) services on innovative and sustainable solutions to transition healthcare supply chains from linear to circular models – REHEAL.","ordregiver":"NHS National Services Scotland (NSS)","ordregiverId":"GB 654 851 612","publiceringsdato":"2025-12-22+01:00","cpvKode":"73100000","cpvTitel":"Forskning og eksperimentel udvikling","formulartype":"Planlægning","formulartypeKode":"planning","tidsfrister":[],"alleOrdregivere":["NHS National Services Scotland (NSS)","Servizo Gallego de Salud – Area Sanitaria de Lugo, A Marina y Monforte de Lemos","Region Hovedstaden (REGIONH)","Fundacja Klaster Lifescience Krakow (KLSK)","Mitera Idiotiki Geniki, Maieytiki, Gynaikologiki Kai Paidiatriki Kliniki Anonymi Etaireia (MITERA)"],"forventetOpstart":"16-06-2026","anslaaetVaerdi":"3000000","anslaaetVaerdiValuta":"EUR","beskrivelse":"This PIN provides early information about the expected starting date and purchase volume and about the open market consultation that is organised in preparation of this precommercial procurement (PCP). The procurement aims to trigger new solutions to be developed and tested to address the following challenge: REHEAL aims to stimulate the development of new solutions that will support the transition of healthcare supply chains from linear to circular models to enhance sustainability and resilience. Key areas include developing supply chain management platforms that prioritise product longevity, material tracking, and regulatory compliance, employing advanced data analytics and AI to optimise reverse logistics and explore recovery opportunities. Solutions should enable scenario analysis and modelling, allowing healthcare providers to identify and implement the most impactful strategies tailored to regional needs.","bkSubTypeKode":"4","bkSubType":"Forhåndsmeddelelse kun anvendt til informationsformål – det generelle direktiv","erAendring":false},"indholdsType":"HENTET_FRA_TED","sekundaereOrdregivere":["Servizo Gallego de Salud – Area Sanitaria de Lugo, A Marina y Monforte de Lemos","Region Hovedstaden (REGIONH)","Fundacja Klaster Lifescience Krakow (KLSK)","Mitera Idiotiki Geniki, Maieytiki, Gynaikologiki Kai Paidiatriki Kliniki Anonymi Etaireia (MITERA)"],"udforelsesstedNutsCode":["ES112","DK012","PL213","EL306"],"udforelsesstedSubLand":["Lugo","Københavns omegn","Miasto Kraków","Δυτική Αττική"],"udforelsesstedLand":["Det Forenede Kongerige","Spanien","Danmark","Polen","Grækenland"],"udforelsesstedBy":["Edinburgh","Lugo","Copenhagen","Kraków","Attiki"],"tilbudsfrister":[],"intressentfrister":[],"deltagelsefrister":[],"svarfrister":[],"antalParts":1,"antalLots":0,"udbudsDokumenter":[]},"opsummeringEN":{"card":{"titel":"PreCommercial Procurement (PCP) to buy R&D (research and development) services on innovative and sustainable solutions to transition healthcare supply chains from linear to circular models – REHEAL.","ordregiver":"NHS National Services Scotland (NSS)","ordregiverId":"GB 654 851 612","publiceringsdato":"2025-12-22+01:00","cpvKode":"73100000","cpvTitel":"Research and experimental development services","formulartype":"Planning","formulartypeKode":"planning","tidsfrister":[],"alleOrdregivere":["NHS National Services Scotland (NSS)","Servizo Gallego de Salud – Area Sanitaria de Lugo, A Marina y Monforte de Lemos","Region Hovedstaden (REGIONH)","Fundacja Klaster Lifescience Krakow (KLSK)","Mitera Idiotiki Geniki, Maieytiki, Gynaikologiki Kai Paidiatriki Kliniki Anonymi Etaireia (MITERA)"],"forventetOpstart":"16-06-2026","anslaaetVaerdi":"3000000","anslaaetVaerdiValuta":"EUR","beskrivelse":"This PIN provides early information about the expected starting date and purchase volume and about the open market consultation that is organised in preparation of this precommercial procurement (PCP). The procurement aims to trigger new solutions to be developed and tested to address the following challenge: REHEAL aims to stimulate the development of new solutions that will support the transition of healthcare supply chains from linear to circular models to enhance sustainability and resilience. Key areas include developing supply chain management platforms that prioritise product longevity, material tracking, and regulatory compliance, employing advanced data analytics and AI to optimise reverse logistics and explore recovery opportunities. Solutions should enable scenario analysis and modelling, allowing healthcare providers to identify and implement the most impactful strategies tailored to regional needs.","bkSubTypeKode":"4","bkSubType":"Prior information notice used only for information – general directive","erAendring":false},"indholdsType":"HENTET_FRA_TED","sekundaereOrdregivere":["Servizo Gallego de Salud – Area Sanitaria de Lugo, A Marina y Monforte de Lemos","Region Hovedstaden (REGIONH)","Fundacja Klaster Lifescience Krakow (KLSK)","Mitera Idiotiki Geniki, Maieytiki, Gynaikologiki Kai Paidiatriki Kliniki Anonymi Etaireia (MITERA)"],"udforelsesstedNutsCode":["ES112","DK012","PL213","EL306"],"udforelsesstedSubLand":["Lugo","Københavns omegn","Miasto Kraków","Δυτική Αττική"],"udforelsesstedLand":["United Kingdom","Spain","Denmark","Poland","Greece"],"udforelsesstedBy":["Edinburgh","Lugo","Copenhagen","Kraków","Attiki"],"tilbudsfrister":[],"intressentfrister":[],"deltagelsefrister":[],"svarfrister":[],"antalParts":1,"antalLots":0,"udbudsDokumenter":[]}}